Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Retained Earnings came in at $590.0 million in Q1 2026, up 1597.52% YoY from $34.8 million in Q1 2025, and up 910.28% on a QoQ basis from -$72.8 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Retained Earnings data on file, last reported at $590.0 million in Q1 2026.

  • Quarterly Retained Earnings rose 1597.52% year-over-year to $590.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $590.0 million (up 1597.52% YoY) and the FY2025 annual result came in at -$72.8 million, down 290.23% from the prior year.
  • Retained Earnings rose to $590.0 million in Q1 2026, from -$72.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $590.0 million in Q1 2026 to a low of -$72.8 million in Q4 2025.
  • A 5-year average of $32.1 million and a median of -$9.9 million in 2022 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2022 — Retained Earnings tumbled 791.21% — and 2026, when it jumped 1597.52%.
  • Tracing CNTN's Retained Earnings over 5 years: stood at -$15.4 million in 2022, then slumped by 60.57% to -$24.7 million in 2023, then jumped by 254.95% to $38.3 million in 2024, then slumped by 290.23% to -$72.8 million in 2025, then surged by 910.28% to $590.0 million in 2026.
  • The last three Retained Earnings figures came in at $590.0 million (Q1 2026), -$72.8 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 594.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 594.38 Mn
Mar 31, 2026 590.02 Mn
Dec 31, 2025 470.81 Mn
Sep 30, 2025 49.62 Mn
Jun 30, 2025 41.73 Mn
Mar 31, 2025 -39.44 Mn
Dec 31, 2024 38.28 Mn
Sep 30, 2024 36.17 Mn
Jun 30, 2024 36.05 Mn
Mar 31, 2024 34.08 Mn
Dec 31, 2023 33.90 Mn
Sep 30, 2023 24.05 Mn
Jun 30, 2023 23.55 Mn
Mar 31, 2023 21.34 Mn
Dec 31, 2022 21.00 Mn
Sep 30, 2022 20.79 Mn
Jun 30, 2022 20.55 Mn
Mar 31, 2022 20.19 Mn
Dec 31, 2021 -6.91 Mn
Dec 31, 2020 -4.70 Mn